GREENBROOK APPOINTS PETER WILLETT AS CHIEF FINANCIAL OFFICER
- None.
- None.
Mr. Willett was appointed Interim Chief Financial Officer of the Company in October 2023, prior to which he has been a key player on the Greenbrook finance team over the past six years, serving as its Senior Vice President of Finance. Peter brings over 11 years of finance experience, providing a broad base of experience and specialized knowledge about the financial and accounting matters that are unique to the mental health services industry.
Peter has been instrumental in developing and implementing the financial strategies that have been successful in improving reporting functions and cost controls for Greenbrook. Peter has a proven track record of identifying effective processes and procedures to improve quality, accuracy, and efficiency in accounting and financial operations.
Operating through 130 Company-operated treatment centers, Greenbrook is a leading provider of Transcranial Magnetic Stimulation ("TMS") therapy and Spravato® (esketamine nasal spray), FDA-cleared, non-invasive therapies for the treatment of Major Depressive Disorder ("MDD") and other mental health disorders, in
View original content:https://www.prnewswire.com/news-releases/greenbrook-appoints-peter-willett-as-chief-financial-officer-302047168.html
SOURCE Greenbrook TMS Inc.
FAQ
Who has been appointed as the full-time Chief Financial Officer of Greenbrook TMS Inc.?
What is the ticker symbol for Greenbrook TMS Inc.?
How many years of finance experience does Mr. Peter Willett bring?